Opioid Peptides Stimulate Rather Than Inhibit Cell Signaling in the Smell Center | Research

The takeaway

In the olfactory bulb, opioid peptides stimulated adenylate cyclase by ~40% — the opposite of their usual inhibitory effect elsewhere in the brain — with beta-endorphin being most potent.

~40% stimulation (not inhibition)
Opioid peptides had the opposite effect in the olfactory bulb compared to most other brain regions

What the researchers found

All three opioid peptides stimulated adenylate cyclase in olfactory bulb by ~40% above baseline. Beta-endorphin was most potent (EC50 22 nM). Naloxone blocked all effects.

Why it matters

This finding challenges the assumption that opioid receptors always inhibit cell activity. In the olfactory bulb, they do the opposite, which could affect how we understand smell processing and opioid drug effects.

How the study worked

Rat olfactory bulb homogenates were treated with opioid peptides at various concentrations. Adenylate cyclase activity was measured. Naloxone antagonism confirmed receptor involvement.

What this study cannot tell us

In vitro study using tissue homogenates, which disrupts normal cellular context. Only one brain region examined. Rat findings may differ from humans.

How to read the evidence

Preliminary in-vitro study using tissue homogenates. The stimulatory effect is clear but the mechanism needs further investigation.

When this study was published

Published in 1991. Region-specific opioid receptor coupling is now better understood.

The bigger picture

This challenges the textbook view that opioid receptors always inhibit cells. In the smell center, they excite cells — which could affect how odors are processed and why certain smells trigger emotional or pain-related responses.

Questions still open

Why do opioid receptors stimulate in the olfactory bulb but inhibit elsewhere?
Do opioid drugs affect sense of smell?

Common questions

How can the same receptor do opposite things in different brain regions?

Opioid receptors can couple to different G-proteins depending on the cell type. In most neurons, they couple to inhibitory G-proteins. In the olfactory bulb, they appear to couple to stimulatory G-proteins — completely changing the effect.

Could this affect how pain patients experience smell?

Possibly. Since opioid medications affect opioid receptors throughout the brain including the olfactory bulb, they could alter smell perception — though this hasn't been systematically studied.

Read the original research

Naturally occurring opioid receptor agonists stimulate adenylate cyclase activity in rat olfactory bulb.

Molecular pharmacology, 39(4), 436-41

View on PubMed ↗

Citation

Onali, P; Olianas, M C. (1991). Naturally occurring opioid receptor agonists stimulate adenylate cyclase activity in rat olfactory bulb.. Molecular pharmacology, 39(4), 436-41.